PD‐L1 blockade significantly radiosensitized tumors after 20 Gy, but mice in both the RT alone and the RT + anti‐PD‐L1 groups developed grade 2 radiation dermatitis that forced termination of the experiment at approximately day 35 (Appendix Fig S9A). The gene discussed is CD274; the disease is radiodermatitis.